Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition

scientific article published on 02 April 2010

Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.EJPHAR.2010.02.058
P698PubMed publication ID20371229
P5875ResearchGate publication ID223808695

P2093author name stringGerard J Marek
P433issue1-3
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)81-90
P577publication date2010-04-02
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleMetabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition
P478volume639

Reverse relations

cites work (P2860)
Q35080459Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain
Q30448534Allosteric modulation of metabotropic glutamate receptors
Q42685336Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.
Q38700682Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP, Long-Term Potentiation, and Disrupts Memory Reconsolidation
Q34373958Development of allosteric modulators of GPCRs for treatment of CNS disorders
Q53824244Divergence in problem-solving skills is associated with differential expression of glutamate receptors in wild finches.
Q60048499Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors
Q38017279Functional selectivity in GPCR heterocomplexes.
Q28485971Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans
Q26744729Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
Q35738531Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex
Q30747587LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment
Q30619467Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction
Q38175882N-Acetylcysteine and metabotropic glutamate receptors: implications for the treatment of schizophrenia: a literature review
Q36675499NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test
Q30465008NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Q54222076Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats.
Q34661281Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
Q30379983Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?
Q35760210Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.
Q26852047Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
Q38031831Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
Q30460392Targeting glutamate synapses in schizophrenia
Q26828004The function of metabotropic glutamate receptors in thalamus and cortex
Q38213709The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment
Q35623415The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex
Q33934716The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats
Q43058779The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-/-), GRM3(-/-) and GRM2/3(-/-) knockout mice.
Q34470910mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure

Search more.